Loading
MedCap AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 09 Feb 2026.
MedCap AB (publ): what insiders have been doing
MedCap AB (publ) is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. Between 18 October 2025 and 18 October 2026, 4 insiders published 5 filings.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €73k) and 4 sales (3 insiders, €254k). On balance, insiders were net sellers of €181k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 board member among the declarants. Karl Tobieson filed the largest sale, €146k, on 5 December 2025, which represents 0.020% of the company's market value.
The last purchase on record was published on 9 February 2026, which is 251 days ago. Most trades are made public on the day they happen. The legal deadline for notifying a trade is three business days (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (890 companies, median 7 filings), a count of 5 filings is below the norm. The full history, which starts in 2025, counts 1 purchase against 4 sales.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€73,187
1 ops. · all time
Sell Volume
€254,246
4 ops. · all time
Who traded when
BuySaleTove Christiansson2 sales
Anders Larnholt1 buy
Anders Larnholt Förvaltning AB1 sale
Karl Tobieson1 sale
Since the insiders bought
- +7.4%Entry SEK 499.50 · Close 16 Oct 2026 SEK 536.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 8,280 of 24,161 companies
59.3
score / 100
Value45
Quality74
FCF yld3.4%
Earn yld2.7%
EV/EBITDA18.3x
ROE16%
Gross mgn59%
Net mgn10%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 546.00
Analyst consensus
2 analystsSEK 620.00Target SEK 640.00(+17%)SEK 660.00
Income statement
RevenueSEK 2.1B
Gross profitSEK 1.2B59% margin
EBITDASEK 473.8M22% margin
Net incomeSEK 219.8M10.7% margin
Valuation
PER (trailing)34.0x
PER (forward)22.6x
P/Book5.2x
Beta0.49
Balance sheet & cash
Market capSEK 8.2B
Total debtSEK 482.9M
Free Cash FlowSEK 280.5M
Debt / Equity29%
Profitability & ownership
ROE16.4%
ROA8.1%
% insiders20.9%
% institutions53.7%
Last declaration on 9 February 2026
Declarations5 total
1,500 shares@ SEK 518.000.0099% mcap100.0% of flowAktieISIN SE0009160872FI:A003V794-1
1,500 shares@ SEK 520.000.0099% mcap100.0% of flowAktieISIN SE0009160872FI:A003V795-1
Canonical exit: 10 May 2026 (T+90)
500 shares@ SEK 539.000.0034% mcap71.4% of flowAktieISIN SE0009160872FI:A003V730-1
3,000 shares@ SEK 534.300.020% mcap100.0% of flowAktieISIN SE0009160872FI:A003U465-1
175 shares@ SEK 630.000.0014% mcap28.6% of flowAktieISIN SE0009160872FI:A003T240-1
5 of 5 declarations
About MedCap AB (publ)
MedCap AB (publ) is a Swedish company operating in the healthcare and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
